Status: current, Defined. Date: 31-Mar 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4338501000168116 | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 15 mL, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4338511000168118 | Serenace 2 mg/mL oral liquid, 15 mL, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Serenace 2 mg/mL oral liquid, 15 mL, bottle | Is a | Serenace 2 mg/mL oral liquid, 15 mL | true | Inferred relationship | Some | ||
| Serenace 2 mg/mL oral liquid, 15 mL, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Serenace 2 mg/mL oral liquid, 15 mL, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Serenace 2 mg/mL oral liquid, 15 mL, bottle | has TP | Serenace | true | Inferred relationship | Some | ||
| Serenace 2 mg/mL oral liquid, 15 mL, bottle | has TPUU | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | true | Inferred relationship | Some | 1822376735 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR